A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine
Clinical trial NCT04152083 · COMPLETED
Trial details
- NCT number
- NCT04152083
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-07
- Primary completion
- 2020-07-08
- Enrollment
- 485
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.